Company Overview and News

 
BHP Billiton (BHP) Lowers Iron-Ore Production View for FY18

2018-04-19 zacks
BHP Billiton Limited (BHP - Free Report) recently released third-quarter fiscal 2018 (ended March 2018) operational results. Aggregate iron-ore output came in at 58 million tons (Mt) during the reported quarter, up 8% year over year. However, the company lowered its iron-ore production guidance for fiscal 2018 (ending June 2018) from 239-243 Mt to 236-238 Mt range. The company stated that the outlook has been revised primarily due to the ongoing car dumper reliability problems.
Upvote Downvote

 
3 Top Gold Stocks for a Safe Haven After Syria Attacks

2018-04-17 investorplace
Gold prices hit $1,350 per ounce for the 13th time in the last five years in yesterday’s trading, after hovering around the psychological level of $1,300 over the last week.The prime catalyst behind the rally was the military attacks in Syria, spearheaded by the United States and its allies.
Upvote Downvote

 
3 Top Gold Stocks for a Safe Haven After Syria Attacks

2018-04-17 zacks
Gold prices hit $1,350 per ounce for the 13th time in the last five years in yesterday’s trading, after hovering around the psychological level of $1,300 over the last week.The prime catalyst behind the rally was the military attacks in Syria, spearheaded by the United States and its allies. Furthermore, war-related geopolitical risks are lifting up crude oil prices, in turn boosting gold’s value in the market.
Upvote Downvote

 
Golden Minerals Announces Filing of NI 43-101 Technical Report for El Quevar Silver Project

2018-04-16 globenewswire
GOLDEN, Colo., April 16, 2018 (GLOBE NEWSWIRE) -- Golden Minerals Company (NYSE American:AUMN) (TSX:AUMN) (“Golden Minerals”, “Golden” or “the Company”) is pleased to announce the filing on SEDAR of a Technical Report for its El Quevar silver project (the “Report”) entitled “NI 43-101 Technical Report on Updated Mineral Resource Estimate” in Salta Province, Argentina. The Report dated February 26, 2018 was prepared in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects by the independent firm of Amec Foster Wheeler E&C Services, Inc.
Upvote Downvote

 
Vale Downgraded to Hold as Iron Ore Price Slump Hits Miners

2018-03-29 zacks
On Mar 29, Vale S.A. (VALE - Free Report) was downgraded by a notch to a Zacks Rank #3 (Hold). Going by the Zacks model, companies holding a Zacks Rank #3 have chances of performing in line with the broader market in the next one to three months. Why the Downside? Miners are in doldrums as iron ore prices enter bear-market territory. On Mar 21, spot price for benchmark 62% fines dropped 3.1% to $63.
Upvote Downvote

 
Ecopetrol, CONSOL Coal and Lululemon Athletica as Zacks Bull and Bear of the Day

2018-03-28 zacks
Chicago, IL – March 28, 2018 – Zacks Equity Research highlights Ecopetrol (EC - Free Report) as the Bull of the Day and CONSOL Coal Resources (CCR - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Lululemon Athletica (LULU - Free Report) .
Upvote Downvote

 
Zacks.com featured highlights include: Post, Golden Minerals, Extreme Networks, Insight and Regal Beloit

2018-03-28 zacks
Chicago, IL – March 28, 2018 - Stocks in this week’s article Post Holdings Inc. (POST - Free Report) , Golden Minerals Company (AUMN - Free Report) , Extreme Networks Inc. (EXTR - Free Report) , Insight Enterprises Inc. (NSIT - Free Report) and Regal Beloit Corporation (RBC - Free Report) .
Upvote Downvote

1
5 Top-Ranked Rising P/E Stocks to Entice Investors

2018-03-27 zacks
Investors are well aware of low P/E investing and its positives. The common investor perception is that the lower the P/E, the higher will be the value of the stock. This inference is drawn on the simple logic that a stock’s current market price does not justify (or is not equivalent to) its higher earnings and therefore has room to run.
Upvote Downvote

2
Golden Minerals Reports Third Quarter 2017 Results

2017-11-07 marketwired
GOLDEN, CO--(Marketwired - Nov 7, 2017) - Golden Minerals Company ("Golden Minerals", "Golden" or "the Company") (NYSE American: AUMN) (TSX: AUMN) today provided a business summary and financial results for the third quarter ended September 30, 2017.
Upvote Downvote

 
Golden Minerals 10-Q (Quarterly Report)

2017-08-08 sec.gov
aumn_Current Folio_10Q Table of Contents     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   FORM 10-Q (MARK ONE)       [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2017.   OR   [  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   FOR THE TRANSITION PERIOD FROM                 TO                    COMMISSION FILE NUMBER 1-13627   GOLDEN M
Upvote Downvote

 
Golden Minerals EX-10.2

2017-08-03 sec.gov
Exhibit 10.2   Execution Version   SECOND AMENDMENT   TO   MASTER AGREEMENT AND LEASE AGREEMENT   This Second Amendment (“Amendment”) to Master Agreement and Lease Agreement between Minera William S.A. de C.V. (hereinafter “William”) and Minera Hecla, S.A. de C.V. (hereinafter “Hecla”) is entered into and effective the 2nd day of August, 2017.   W I T N E S S E T H   WHEREAS, the parties entered into a Master Agreement and Lease Agreement dated July 15, 2015 (the “Original Agreement”), as amende
Upvote Downvote

 
Golden Minerals EX-10.1

2017-08-03 sec.gov
Exhibit 10.1   Execution Version   OPTION AGREEMENT   This Option Agreement (this “Agreement”) among Golden Minerals Company (“Golden Minerals”) and Hecla Mining Company, located at 6500 N. Mineral Dr., Ste 200, Coeur d’ Alene, Idaho 83815 (“Hecla Mining”) is entered into and effective the 2nd day of August, 2017 (the “Effective Date”).   W I T N E S S E T H   WHEREAS, Minera William S.A. de C.V., a subsidiary of Golden Minerals (“William” and together with Golden Minerals, the “Company”) and Mi
Upvote Downvote

 
Golden Minerals 8-K (Current Report/Significant Event)

2017-08-03 sec.gov
Table of Contents       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   Current Report   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  August 2, 2017   GOLDEN MINERALS COMPANY (Exact name of registrant as specified in its charter)   DELAWARE   1-13627   26-4413382 (State or other jurisdiction of incorporation or organization)   (Commission File Number)   (I.
Upvote Downvote

 
Golden Minerals AUTO-GENERATED PAPER DOCUMENT

2017-06-21 sec.gov
This document was generated as part of a paper submission. Please reference the Document Control Number 15007345 for access to the original document.
Upvote Downvote

 
Golden Minerals 8-K (Current Report/Significant Event)

2017-06-21 sec.gov
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   Current Report   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  May 21, 2015   GOLDEN MINERALS COMPANY (Exact name of registrant as specified in its charter)   DELAWARE   1-13627   26-4413382 (State or other jurisdiction of incorporation or organization)   (Commission File Number)   (I.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...